PCOS Phenotype in Unselected Populations Study (P-PUP): Protocol for a Systematic Review and Defining PCOS Diagnostic Features with Pooled Individual Participant Data.

Creative Commons License

Kiconco S., Mousa A., Azziz R., Enticott J., Suturina L. V., Zhao X., ...More

Diagnostics (Basel, Switzerland), vol.11, no.11, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 11
  • Publication Date: 2021
  • Doi Number: 10.3390/diagnostics11111953
  • Journal Name: Diagnostics (Basel, Switzerland)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, INSPEC, Directory of Open Access Journals
  • Keywords: PCOS, polycystic ovaries, Stein-Leventhal, epidemiology, normative cut-offs, phenotype, cluster analysis, hirsutism, androgens, menstrual cycle, PCOM, POLYCYSTIC-OVARY-SYNDROME, ANTI-MULLERIAN HORMONE, FOLLICLE COUNT, CHINESE WOMEN, WHITE WOMEN, PREVALENCE, CRITERIA, HYPERANDROGENEMIA, METAANALYSIS, MANAGEMENT
  • Hacettepe University Affiliated: Yes


The diagnosis of polycystic ovary syndrome (PCOS) remains challenging due to limited data regarding normative cut-offs for the diagnostic features in different subpopulations. We aim to conduct a systematic review, build a comprehensive repository of de-identified individual participant data (IPD), and define normative ranges and diagnostic cut-offs for all PCOS diagnostic features. We will conduct a systematic search of MEDLINE and EMBASE databases for studies that assessed PCOS diagnostic features in unselected women. Two reviewers will assess eligibility and perform quality appraisal. Authors of included studies will be invited to contribute IPD. Primary variables include directly assessed modified Ferriman Gallwey (mFG) scores; menstrual cycle lengths; follicle number per ovary (FNPO), ovarian volume (OV), anti-Mullerian hormone (AMH); circulating androgens, including total testosterone (TT), free testosterone, bioavailable testosterone, free androgen index (FAI), androstenedione (A4), and dehydroepiandrosterone sulphate (DHEAS). Normative ranges and cut-offs will be defined using cluster analysis. Monash University Human Research Ethics Committee granted ethical approval (26938/0 1/12/2020), all IPD will be de-identified and primary studies have ethical approval from their institutional ethics committees. Findings will clarify distinction between PCOS and non-PCOS populations, and inform the update of the international evidence-based guidelines for the assessment and management of PCOS.